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a b s t r a c t
A case of a 45,X/46,XY boy with gonadal dysgenesis is presented. The patient showed hypospadias and
right undescended testis. He underwent underwent repair surgery for hypospadias, right orchidopexy,
and bilateral testicular biopsy. Testicular biopsy revealed no malignant ﬁnding. He was followed-up
annually by scrotum palpation. When the patient grew up to 24 years old, he was diagnosed to have right
testicular tumor. High orchiectomy revealed pT1 seminoma. The management of undescended testis in
men with gonadal dysgenesis and disordered sexual development is discussed.
 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Karyotype 45,X/46,XY gonadal dysgenesis (GD) results in DSD.
Individuals with 45,X/46,XY GD are also known to be at increased
risk of developing GCTs.1 This risk of malignancy has been
associated with gender phenotype and gonad location. Patients
with a female phenotype or intra-abdominal testes have greater
risks of malignancy, and their gonads should thus be removed
prophylactically in early childhood. In contrast, 45,X/46,XY GD
males with scrotal testes are classiﬁed as having a lower risk of
malignancy, and the gonads may thus be preserved.2 However,
the precise risk of malignancy in the undescended testis after
surgery remains unclear and the standard management of such
patients has not been determined. Here we report a case of a
45,X/46,XY GD male in whom early-stage GCT developed in the
undescended testis during a 21-year follow-up period after
orchidopexy.
Case presentation
A 3-year-old boy had been referred to a previous hospital with
hypospadias and right undescended inguinal testis. A chromosome
test revealed a 45,X/46,XY mosaicism karyotype. He underwent
repair surgery for hypospadias, right orchidopexy, and bilateral
testicular biopsy. Testicular biopsy revealed no malignant ﬁnding.
He was followed-up annually by scrotum palpation.
At 17 years old, the patient was referred to our hospital for
further follow-up. His height and weight were 156 cm and 51 kg,
respectively. Breast and pubic hair development were consistent
with Tanner grade 2. His external genitalia appeared male, with a
short penis. His bilateral testes were palpable in his scrotum, with
no abnormal masses. The right testis was smaller than the left and
had microlithiasis on US.
His FSH level of 12.7 IU/L, LH level of 8.5 IU/L, and testosterone
level of 358.3 pg/mL were within the normal ranges. The tumor
markers Human Chorionic Gonadotropin-b, Alpha-Fetoprotein, and
Lactate Dehydrogenase were all normal. Because he had received a
testicular biopsy at age 3, he was scheduled to receive follow-up by
periodic scrotal palpation, US, and tumor marker tests every
6 months, without further testicular biopsy.
At 24 years old, a 10 mm testicular mass was identiﬁed on US
(Fig. 1). The mass was not palpable, but MRI revealed a solitary
mass in his right testis (Fig. 2). Abdominal and thoracic CT revealed
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no metastatic lesions. Tumor markers were within the normal
ranges. Semen analyses revealed azoospermia. More precise
chromosomal study revealed loss of the Y chromosome in the AZF
bþc area.
He was diagnosed with a localized right testicular tumor, and
underwent right high orchiectomy and left testicular biopsy.
Pathological analyses revealed seminoma with mature teratoma
(pT1) in the right testis and no malignancy in the left testis (Fig. 3).
His regular follow-up continued for 1 year after surgery, with no
evidence of disease recurrence. His FSH, LH, and testosterone levels
remained within normal ranges.
Discussion
The incidence of 45,X/46,XY GD is estimated to be <1 in 15,000
live births. The gender phenotypes are distinguished by external
genitalia features, and vary among female, male, and ambiguous
(signiﬁcant genitalia anomaly).2
The Consensus Statement on Management of Intersex Disorder
was published in 2006.3 This statement classiﬁed the various kar-
yotypes of DSDs, including 45,X/46,XY, into high-, intermediate-,
and low-risk groups for GCT. The risk of malignancy in 45,X/46,XY
GD patients with intra-abdominal testes was 15e35%, which was
assigned to the high-risk group, while the risk of malignancy in
female gender phenotype 45,X/46,XY was much higher than in
male phenotype individuals (22.5e50%). Unilateral or bilateral go-
nadectomy has been recommended for these patients at high risk of
malignancy. In contrast, patients with scrotal testes were assigned
to the intermediate-risk group. However, the precise risk of ma-
lignancy remains unknown, because male 45,X/46,XY GD patients
may remain undiagnosed until adulthood. A previous patient was
only diagnosed as 45,X/46,XY GD as an adult after surgery for GCT
in the scrotal testis.4 To the best of our knowledge, the current case
provides the ﬁrst report of the development of GCT in a 45,X/46,XY
male patient after 20 years of follow-up from the ﬁrst diagnosis.
In recent years, a proposed treatment strategy for GD males has
involved retaining their gonads in order tomaintain their hormonal
functions and gender identity.5 Orchidopexy and biopsy in child-
hood are recommended in the case of patients with undescended
gonads. Palpation and self-examination are easy and US follow-up
is efﬁcient in scrotal gonads or after orchidopexy. Repeat biopsy
should be considered, depending on the results of the ﬁrst biopsy,
and gonadectomy should be recommended if carcinoma in situ
(CIS) or gonadoblastoma is detected on biopsy. In the present case,
we decided to preserve the patient’s gonads because of his male
Figure 1. US ﬁndings of right testis. Arrows indicate the testicular tumor.
Figure 2. Magnetic resonance imaging ﬁndings. Images taken by T1WI (left) and T2WI (right). Arrows indicate the testicular tumor.
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phenotype, scrotal testes after orchidopexy, and negative malig-
nancy on biopsy at age 3 years. However, GCT had developed by
24 years old. CIS was previously reported in the testis in ﬁve of 13
45,X/46,XY male patients,2 with four of the CIS patients identiﬁed
after age 10 years. These results indicated that malignant cells may
appear after puberty, even when no CIS is detected on testicular
biopsy in early childhood. In our case, the GCT was fortunately
detected at an early stage and completely resected, with close
follow-up. However, testicular re-biopsy after puberty could be an
optional treatment strategy in these patients. More outcome re-
ports of conservative management of gonads in this karyotype are
needed to establish a therapeutic policy for GD patients, classiﬁed
according to their malignancy risk.
Conclusion
Close follow-up of a 45,X/46,XY GD male patient with intact
scrotal gonads enabled the detection of a testicular tumor at an early
stage. This case suggests that gonadsmay be preserved in 45,X/46,XY
GD males with scrotal testes, though patients with a history of
cryptorchidismmay be at comparatively high risk of developing GCT.
Appropriate risk assessment of each patient is thus needed before
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Figure 3. Microscopic ﬁndings (HematoxylineEosin staining). Left image, seminoma; right image, teratoma.
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